Viewing Study NCT06277050


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2026-01-02 @ 12:04 AM
Study NCT ID: NCT06277050
Status: RECRUITING
Last Update Posted: 2024-04-30
First Post: 2024-02-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
Sponsor: Jiangxi Provincial Cancer Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nasopharyngeal Carcinoma View
None High-Risk Cancer View
None Maintenance Therapy View
Keywords: